Introduction {#s1}
============

Chronic subdural hematoma (CSDH), typically associated with neurological deterioration after a mild head trauma in elderly patients, is one of the most common neurosurgical disorders. [@pone.0103703-Nordstrom1], [@pone.0103703-DeBonis1] Albeit usually amenable to surgery, CSDH has been reported to have a significantly high recurrence rate, ranging from 5% to 30%. [@pone.0103703-BerghauserPont1], [@pone.0103703-Janowski1] Although various irrigation agents such as 5% dextrose solution (D5W), normal saline (NS), lactated Ringer\'s solution (LR), and artificial cerebrospinal fluid (ACF) are commonly used in neurosurgery ([Table 1](#pone-0103703-t001){ref-type="table"}), the role of irrigation solution has not been sufficiently assessed in the treatment of CSDH.

10.1371/journal.pone.0103703.t001

###### Composition of solutions used in neurosurgery.

![](pone.0103703.t001){#pone-0103703-t001-1}

  Component                D5W         NS          LR          ACF
  -------------------- ----------- ----------- ----------- -----------
  Na^+^ (mEq/L)             0          154         130         145
  K^+^ (mEq/L)              0           0           4          2.8
  Mg^2+^ (mEq/L)            0           0           0          2.2
  Ca^2+^ (mEq/L)            0           0           3          2.3
  Cl^-^ (mEq/L)             0          154         109         129
  HCO~3~ ^-^ (mEq/L)        0           0           0         23.1
  P (mM/L)                  0           0           0          1.1
  Lactate^-^ (mEq/L)        0           0          28           0
  Glucose (g/L)            50           0           0         0.61
  Osmolality ratio      about 0.9   about 0.9   about 0.9    about 1
  pH                    about 5.0   about 6.7   about 6.7   about 7.3

Abbreviations: D5W: 5% dextrose solution, NS: Normal saline, LR: Lactated Ringer\'s solution, ACF: Artificial cerebrospinal fluid.

ACF is used as an irrigation fluid during neurosurgical procedures, because its composition is similar to that of human cerebrospinal fluid (CSF). [@pone.0103703-Leen1], [@pone.0103703-Elliott1] Because of its enhanced brain-protective properties compared with conventional commercial solutions such as D5W [@pone.0103703-Nordstrom1], NS, [@pone.0103703-Higuchi1] or LR [@pone.0103703-Santarius1], it has been used routinely, for example, in more than 1000 Japanese facilities, particularly after being marketed as a 500 mL double bag system (Artcereb, Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan). [@pone.0103703-Oka1], [@pone.0103703-Shimizu1] ACF also attenuates edema around a traumatic wound, minimizes cerebrovascular permeability and cell damage, [@pone.0103703-Koizumi1] and achieves faster hemostasis without interrupting normal coagulation, [@pone.0103703-Fujita1] than the other solutions.

The aim of the present study was to evaluate the relationship between the outcome of CSDH and various perioperative and intraoperative factors including the type of irrigation solution used. Here, we report on our 6-year single-center experience with CSDH, focusing on numerous factors associated with prognosis. ACF irrigation, one of the newly established prevalent factors in this study, has been known to be efficacious for intraventricular [@pone.0103703-Oka1] or cisternal irrigation, [@pone.0103703-Shimizu1] but no evidence about subdural irrigation/drainage existed. Therefore, we studied the possible beneficial effects of using ACF intraoperatively as an irrigation solution.

Methods {#s2}
=======

Study design {#s2a}
------------

One hundred and twenty unilateral CSDH patients, who were admitted to the Chiba Cardiovascular Center for surgery (prefrontal burr-hole and overnight drainage) between September 2007 and March 2013, were analyzed in this study. All patients in this hospital cohort were symptomatic, and no patients were excluded. The first 60 patients were irrigated with NS (NS group), and the rest with ACF (ACF group).

Ethics Statement {#s2b}
----------------

Before the surgery, written informed consent was obtained from all patients and/or family members. The study protocol was approved by the ethics committee of our center (Chiba Cardiovascular Center Ethical Review Board, IRB\# 11000598).

Surgical technique {#s2c}
------------------

Under local anesthesia and modified neuroleptanalgesia with pentazocine and diazepam, the patients underwent surgery, which included the creation of a prefrontal burr-hole, incision of the dura mater, and irrigation of the hematoma. Subdural collections were washed out with NS (n = 60) or ACF (n = 60) through a silicone catheter. Next, the subdural space was filled with either NS or ACF, and the scalp was closed in two layers. The catheter was inserted anteriorly, connected to a soft collection bag (Silascon Subdural Drainage Set, Kaneka. Medix Co., Osaka, Japan), and maintained at the head level. [@pone.0103703-Santarius1] The drainage catheter was removed the next day. Ambulation was generally allowed 3 days after the operation.

Clinical and radiological data {#s2d}
------------------------------

Patient characteristics such as age, gender, and past medical history, including medication use, were recorded at the time of admission. Focal neurological signs including dysarthria, hemiparesis, and headache were also noted. Because a previous study identified preoperative laboratory parameters as possible predictors of CSDH recurrence, the same data sets, including preoperative platelet count, white blood cell count, and international normalized ratios of prothrombin time (PT-INR), were also collected in this study. [@pone.0103703-BerghauserPont1] The perioperative changes in general neurological status and global disability were assessed using the Glasgow Coma Score (GCS) and modified Rankin scale (mRS), respectively. Hematoma laterality, type, [@pone.0103703-Nakaguchi1] and volume were calculated [@pone.0103703-Sucu1] as XYZ/2 and evaluated by computed tomography (CT) at least three times in each patient: preoperatively, 1 day and 1 week (5--7 days) postoperatively, and whenever needed. All of the patients were followed-up for more than 6 months on an outpatient basis; when neurological deterioration reappeared, the patient was further evaluated using CT scans. Based on a combination of symptoms and CT findings, recurrence was defined as a state requiring reoperation for relapsed neurological symptoms with compression of the brain by an increase in hematoma volume, as relying only on symptoms or CT findings may lead to measurement and detection biases.

Specimen Preparation {#s2e}
--------------------

To elucidate the mechanisms underlying ACF\'s ability to reduce recurrence, we carried out histological exploration after the cohort analysis with 6 patients. A piece of the hematoma membrane from each patient was excised for histological examination. Each membrane (∼10 mm^2^) was cut into three pieces with a razor blade. One piece was fixed in 10% buffered formalin immediately after the surgery or after incubation in the liquid hematoma as a control. The other two pieces were fixed after different incubation times (3, 6, and 24 h) in either NS or ACF at 37°C and embedded in paraffin. These membranes were stained with hematoxylin and eosin, and then examined microscopically.

Statistical analysis {#s2f}
--------------------

SAS 9.4 and JMP 9 software (SAS Institute, Cary, NC) were used for statistical analyses. Continuous variables were compared between each group by using Student\'s *t*-tests and are reported as the mean ± the standard deviation (SD). The median values from all patients are also presented in continuous data and ordered categorical data. Fisher\'s exact test and χ^2^ tests were performed on proportional data. Because early readmission is associated with a poor prognosis, [@pone.0103703-Lum1] we also used log-rank tests to evaluate the association of patient characteristics with recurrence. To perform the log-rank tests, continuous and categorical data were grouped by dichotomization with the median value.

Preoperative and intraoperative variables, which were highly associated with CSDH recurrence (*P*\<.15 in the univariate analysis, *P*\<.10 in the log-rank test), were subjected to further analyses to adjust for possible confounding factors. Postoperative factors were not included in the analyses to avoid multicolinearity. First, multivariate analysis was carried out using logistic regression models with these variable sets and with the propensity scores determined from these variable sets. Additionally, because of the cohort nature of this study, [@pone.0103703-Vandenbroucke1] the Cox proportional hazards model was used to assess the cumulative recurrence rate. Furthermore, we determined how sensitive the model was to the removal of the propensity regression variables. Tests for effect modifications included the addition of interaction terms for each variable to the model. For all analyses, a *P* value of \<.05 was considered statistically significant. Five values of the PT-INR were missing because of incomplete routine laboratory work-ups, and these five PT-INR values were excluded from univariate analyses.

Results {#s3}
=======

Patient characteristics are listed in [Table 2](#pone-0103703-t002){ref-type="table"}. The overall recurrence rate was 9.2%, with 11 patients (5 men and 6 women) out of the 120 patients experiencing recurrence during the 6 months of follow-up. Two patients (3.3%) in the ACF group and 9 patients (15%) in the NS group required additional operations ([Table 3](#pone-0103703-t003){ref-type="table"}). Therefore, the use of ACF resulted in an observed crude absolute risk reduction of 11.7%. [Figure 1](#pone-0103703-g001){ref-type="fig"} illustrates the postoperative cumulative recurrence rates of these patients (*P* = .027, log-rank test).

![Cumulative recurrence rate of chronic subdural hematoma after surgery.\
The difference between the normal saline (NS) group and the artificial cerebrospinal fluid (ACF) group is statistically significant (*P* = .027, log-rank test).](pone.0103703.g001){#pone-0103703-g001}

10.1371/journal.pone.0103703.t002

###### Patient characteristics: median values and univariate analyses (t, U, χ^2^, and Fisher\'s exact tests).

![](pone.0103703.t002){#pone-0103703-t002-2}

                                               No. of patients (%)      *P* value     
  ------------------------------------ ------ --------------------- ----------------- ------------
  Age (years)                            79         77.4±10.9           76.1±12.0         .53
  Age (≥80 years)                                   28 (47%)            25 (42%)          .092
  Gender (female)                                   21 (35%)            23 (38%)          .34
  **On admission**                                                                    
  GCS 6/9/11/12/13/14/15                 14      0/2/1/3/4/28/22     1/0/0/3/9/24/23   .64 (\<14)
  mRS 0/1/2/3/4/5                        3       0/11/12/11/18/8     0/11/11/15/17/6   ≥.99 (≥3)
  Dysarthria                                        16 (27%)            12 (20%)          .51
  Hemiparesis                                       57 (95%)            53 (88%)          .32
  Headache                                          17 (28%)            23 (38%)          .33
  **Past history**                                                                    
  Cerebrovascular accident                          14 (23%)             9 (15%)          .35
  Diabetes mellitus                                  9 (15%)            14 (23%)          .35
  Hypertension                                      31 (52%)            32 (53%)          ≥.99
  Heavy drinking                                    14 (23%)             9 (15%)          .35
  Ischemic heart disease                             7 (12%)             5 (8%)           .76
  Tumor                                              7 (12%)             6 (10%)          ≥.99
  Drug history (anticoagulant)                       7 (12%)             6 (10%)          ≥.99
  Drug history (antiplatelet)                       21 (35%)            13 (22%)          .16
  **CT findings**                                                                     
  Laterality (left)                                 29 (48%)            32 (53%)          .72
  Hyper/Iso/Hypo/Layer/Grad/Sep/Trab             12/9/5/8/5/7/14     12/5/7/8/6/8/14   .79--≥.99
  Hematoma cavity volume (mL)           137          147±49              149±49           .76
  Preoperative laboratory data                                                        
  Leukocytes, ×10^9^/L                  6.60        7.21±2.77           7.01±2.68         .69
  Thrombocytes, ×10^9^/L                220          250±85              209±103        **.02**
  PT-INR                                1.00       1.02±0.096          1.00±0.095         .11
  **Complications**                                                                   
  Transient postoperative delirium                  12 (20%)            11 (18%)          ≥.99
  Urinary tract infection                            3 (5%)              1 (2%)           .62
  **Postoperative data**                                                              
  GCS (10/12/13/14/15)                   15        0/1/1/16/42         1/1/0/18/40     .84 (\<14)
  mRS 0/1/2/3/4/5                        1         30/10/4/7/9        23/15/5/8/8/1    ≥.99 (≥3)
  Cavity volume (mL) on POD 1           63.9          71±32               69±40           .83
  Cavity volume (mL) on POD 7           62.8          59±37               74±40         **.028**
  Hospital stay (days)                   8           9.5±4.0            10.5±7.2          .37

Values are the mean ± SD when appropriate. Significant values are featured with bold font. Three PT-INR values from the NS group (1 recurrent patient) and 2 PT-INR values from the ACF group were missing and were excluded from analysis. Abbreviations: ACF: Artificial cerebrospinal fluid, NS: Normal saline, GCS: Glasgow Coma Score, mRS: Modified Rankin scale, CT: Computed tomography, Hyper: Hyperdense, Iso: Isodense, Hypo: Hypodense, Layer: Layered, Grad: Gradation, Sep: Separated, Trab: Trabecular, PT-INR: International normalized ratio of prothrombin time, POD: Postoperative day.

10.1371/journal.pone.0103703.t003

###### Factors related to recurrence: univariate analyses (t, U, χ^2^, and Fisher\'s exact tests) and log-rank tests.

![](pone.0103703.t003){#pone-0103703-t003-3}

                                            No. of patients (%)     *P* value      *P* value   
  ---------------------------------------- --------------------- --------------- ------------- ------------------
  Age (years)                                    76.3±11.7          75.1±6.1       **.025**     **.044** (≥80 y)
  Gender (female)                                38 (35%)            6 (55%)          .34             .20
  **On admission**                                                                             
  GCS 6/9/11/12/13/14/15                      1/2/1/6/9/45/45     0/0/0/0/4/7/0   .26 (\<14)       .13 (\<14)
  mRS 0/1/2/3/4/5                            0/21/21/25/29/13      0/1/2/1/6/1     .20 (≥3)         .48 (≥3)
  Dysarthria                                     23 (21%)            5 (46%)          .13             .067
  Hemiparesis                                    99 (91%)           11 (100%)         .63             .31
  Headache                                       38 (35%)            2 (18%)          .33             .26
  **Past history**                                                                             
  Cerebrovascular accident                       19 (17%)            4 (36%)          .22             .12
  Diabetes mellitus                              21 (19%)            2 (18%)         ≥.99             .93
  Hypertension                                   56 (51%)            7 (64%)          .65             .44
  Heavy drinking                                 21 (19%)            2 (18%)         ≥.99             .91
  Ischemic heart disease                         12 (11%)            0 (0%)           .60             .26
  Tumor                                          12 (11%)           1 (9.1%)         ≥.99             .84
  Drug history (anticoagulant)                   12 (11%)           1 (9.1%)         ≥.99             .84
  Drug history (antiplatelet)                    31 (28%)            3 (27%)         ≥.99             .93
  **CT findings**                                                                              
  Laterality (left)                              52 (48%)            9 (82%)         .067           **.03**
  Hyper/Iso/Hypo/Lay/Grad/Sep/Trab          23/15/9/15/10/13/24   1/1/1/1/1/2/4    .28--≥.99        .26--.96
  Hematoma cavity volume (mL)                     147±48             158±53           .45             .36
  Preoperative laboratory data                                                                 
  Leukocytes (×10^9^/L)                           7.2±2.8            6.4±2.2          .39         .33 (\>6.6)
  Thrombocytes (×10^9^/L)                         234±97             186±80           .12       **.037** (≤22.0)
  PT-INR                                         1.01±0.09          1.03±0.12         .53         .80 (≥1.00)
  **Intraoperative irrigation solution**                                                       
  NS versus ACF                                  58 (53%)            2 (18%)         .053           **.027**
  **Complications**                                                                            
  Transient postoperative delirium               19 (17%)            4 (36%)          .22             .10
  Urinary tract infection                        4 (3.7%)           0 (0.0%)         ≥.99             .53
  **Postoperative data**                                                                       
  GCS on POD 5, 10/12/13/14/15                  1/1/1/18/78         0/1/0/6/4     ≥.99 (\<14)      .19 (\<14)
  mRS on POD 5, 0/1/2/3/4/5                   51/21/7/14/15/1      2/4/2/1/2/0     ≥.99 (≥3)        .94 (≥3)
  Cavity volume (mL) on POD 1                      69±36              79±32           .41          .74 (≥64)
  Cavity volume (mL) on POD 7                      63±38              97±31        **.005**      **.044** (≥63)
  Hospital stay (days)                            9.8±5.3           11.6±10.2         .57             .81

Values are the mean ± SD when appropriate. Significant values are featured with bold font. Four PT-INR values from the non-recurrent group and 1 PT-INR value from the recurrent group were missing and were excluded from analysis. Abbreviations: Rec: Recurrence, GCS: Glasgow Coma Score, mRS: Modified Rankin scale, CT: Computed tomography, Hyper: Hyperdense, Iso: Isodense, Hypo: Hypodense, Lay: Layered, Grad: Gradation, Sep: Separated, Trab: Trabecular, PT-INR: International normalized ratio of prothrombin time, NS: Normal saline, ACF: Artificial cerebrospinal fluid, POD: Postoperative day.

Five preoperative PT-INR values did not exist (missing completely at random because of simple measuring loss by the primary doctor). Therefore, we restricted the univariate analysis of PT-INR to the 115 patients that had PT-INR values. The results generated using imputation methods did not differ substantively from the results generated by this case-wise deletion. All other variables were complete.

Among the preoperative and intraoperative factors, age (\<80 years old, *P* = .044), irrigation solution (ACF, *P* = .027), preoperative platelet count (\>22.0, *P* = .037), and laterality (right, *P* = .030) were related to a low recurrence rate with the log-rank test ([Table 3](#pone-0103703-t003){ref-type="table"}). None of the symptoms, such as dysarthria (*P* = .067), showed a statistically significant correlation with recurrence. The only significant factor was the type of irrigation solution used, indicating the effectiveness of ACF ([Table 4](#pone-0103703-t004){ref-type="table"}) in the Cox proportional hazards models. Additionally, logistic regression models using these 5 factors ([Table 4](#pone-0103703-t004){ref-type="table"}) or the propensity score (odds ratio of ACF, 0.18, 95% CI: 0.036--0.94; *P* = .041) showed similar results. The ACF odds ratio changed only .03 when any single variable was removed. No effect modification was detected in these variables (*P* for interaction \>.53).

10.1371/journal.pone.0103703.t004

###### Multivariate analyses of chronic subdural hematoma recurrence^a^.

![](pone.0103703.t004){#pone-0103703-t004-4}

                       Logistic regression analysis   Cox proportional hazards model                                
  ------------------- ------------------------------ -------------------------------- --------- ------ ------------ ----------
  ACF                              0.17                         0.03--0.92             **.04**   0.20   0.04--0.99   **.049**
  Age                              1.08                         0.98--1.18               .12     1.06   0.98--1.15     .06
  Dysarthria                       4.06                         0.91--18.1              .068     3.10   0.90--10.7     .074
  Laterality (left)                3.39                         0.62--18.5               .16     3.15   0.63--15.8     .16
  Thrombocyte                      0.98                         0.90--1.07               .71     0.98   0.92--1.06     .75

Significant values are featured with bold font. Abbreviations: OR: Odds ratio, CI: Confidence interval, ACF: Artificial cerebrospinal fluid.

Amidst the postoperative data, a sharp decrease in the residual subdural cavity volume was observed in CT images on postoperative day (POD) 1 in both groups; however, on POD 5--7, the cavity volume in the ACF group was less than that in the NS group (*P* = .02; [Table 2](#pone-0103703-t002){ref-type="table"}).

Histological alterations in the hematoma membrane {#s3a}
-------------------------------------------------

We observed a striking disorganization with increased luminosity in the hematoma membranes incubated in NS compared to the control or to the membranes incubated in ACF ([Figures 2](#pone-0103703-g002){ref-type="fig"} and [3](#pone-0103703-g003){ref-type="fig"}). Microscopic analysis revealed the loss of extracellular matrix, shrinkage of the cytoplasm, and pyknotic change of nuclei in the outer membranes treated with NS. The chromatin structure was maintained both in the control and in ACF-incubated groups ([Figure 3](#pone-0103703-g003){ref-type="fig"}). Eosinophils infiltrated the loose membrane interstitium in the NS group, whereas they were mostly within the microvascular lumens in the control and ACF groups ([Figure 2](#pone-0103703-g002){ref-type="fig"}).

![Cross sections of the hematoma outer membranes fixed immediately after surgery (Control, left panels) or after 24 h of incubation with artificial cerebrospinal fluid (ACF, center panels) or normal saline (NS, right panels).\
The insets are higher magnifications of the perivascular area. Inflammatory cells, including lymphocytes (orange arrowheads) and eosinophils (yellow arrows), are mostly located in the loose stroma of the hematoma membrane in the NS group, whereas they are confined in the capillary lumen, in the control and ACF groups. Hematoxylin--eosin stain, Burr = 25 µm.](pone.0103703.g002){#pone-0103703-g002}

![The membranes were fixed after 3, 6, or 24 h of incubation.\
Fewer morphological changes are seen in the control (left panels) or ACF groups (center panels), whereas the cytoplasm of constituent cells shrank and the nuclei of most infiltrated cells are pyknotic and deformed (round) in the NS group (right panels). The former alteration is the most noticeable in fibroblasts (green arrows) and the latter in lymphocytes (arrowheads).](pone.0103703.g003){#pone-0103703-g003}

Discussion {#s4}
==========

Several factors are known to increase the risk of CSDH recurrence following burr-hole drainage surgery. However, the involvement of the intraoperative irrigation solution in the recurrence of CSDH has not been examined sufficiently. We identified one prospective randomized study on the effect of ACF on cerebral blood flow and favorable postoperative status after clipping of unruptured cerebral aneurysms, [@pone.0103703-Shimizu1] and one retrospective case-control study on the effect of minimizing inflammation after an endoscopic procedure for aqueduct stenosis. [@pone.0103703-Oka1] Here, we showed that patients with ACF irrigation had a lower recurrence rate than those receiving NS irrigation. No previous studies have explored the use of ACF in burr-hole drainage surgery in CSDH patients to decrease the residual hematoma volume and CSDH recurrence rate.

The space irrigated in this study was subdural rather than subarachnoidal or intraventricular, where CSF is usually located. However, a tear in the subarachnoid membrane has been verified as a cause of CSDH. [@pone.0103703-Kristof1] Furthermore, even without the tear, irrigation fluid is known to influence the arachnoid mater and the underlying brain parenchyma. [@pone.0103703-Doi1] Thus, we postulated that ACF, as compared with NS, would minimize irritation, improve the stability and permeability of the hematoma membrane, and promote another healing process, i.e., the physiological re-expansion of the brain, allowing cavity volume reduction and preventing recurrence.

Since Virchow initially described CSDH as "pachymeningitis haemorrhagica interna," the etiology of CSDH has long been considered to include inflammation. [@pone.0103703-Virchow1], [@pone.0103703-Tang1] In our study, ACF (buffer solution with pH 7.3), which can be less irritating than NS (simple salt solution with pH 6.3), was shown to decrease the damage to the hematoma membranes and the hematoma volume, thus decreasing the recurrence ([Table 2](#pone-0103703-t002){ref-type="table"}, [Figure 1](#pone-0103703-g001){ref-type="fig"}). Based on these theoretical rationales and our clinical data, the use of ACF as an irrigation solution could be beneficial, not only for subarachnoid or intraventricular lesions, but also for subdural lesions.

The primary limitation of this study was that it involved a single advanced medical center. Nevertheless, our hospital cohort included a broad range of patients, from adolescents to elderly individuals and both mild and severe cases, which ensures the generalizability of the results. Further, as our public center is located in a rural area, it also functions as the sole community hospital. In the future, a multicenter parallel group comparison study is necessary for evaluating the specific effects and power of the recurrence reduction in a more general population. This preliminary study suggests that additional rigorous investigations are warranted to determine whether ACF is beneficial for reducing the risk of recurrent CSDH. Currently, two prospective studies are ongoing. [@pone.0103703-Uno1], [@pone.0103703-Iwata1]

Conclusions {#s5}
===========

In the present study, which consisted of 120 consecutive patients, we investigated risk factors related to the recurrence of CSDH and verified the independent role of irrigation solution in CSDH recurrence. Based on our findings, we conclude that irrigation with ACF is associated with a decreased incidence of recurrence.
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